Consonance Capital Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-482,047
| Closed | -$18.7M | – | 28 |
|
|
2016
Q2 | $18.7M | Sell |
482,047
-211,890
| -31% | -$8.22M | 2.65% | 12 |
|
|
2016
Q1 | $28.1M | Sell |
693,937
-712,200
| -51% | -$28.8M | 4.25% | 13 |
|
|
2015
Q4 | $125M | Buy |
1,406,137
+52,224
| +4% | +$4.63M | 16.73% | 1 |
|
|
2015
Q3 | $100M | Buy |
1,353,913
+170,507
| +14% | +$12.6M | 14.1% | 1 |
|
|
2015
Q2 | $95.7M | Buy |
1,183,406
+447,484
| +61% | +$36.2M | 9.61% | 3 |
|
|
2015
Q1 | $30.8M | Buy |
+735,922
| New | +$30.8M | 2.81% | 15 |
|